Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Immuneering Corp
IMRXCurrent price
1.93 USD
+0.01 USD (+0.52%)
Last closed
1.92 USD
Company
immuneering.com
ISIN
US45254E1073
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
55 451 860 USD
Yield for 12 month
-67.29 %
1Y
3Y
5Y
10Y
15Y
IMRX
Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Address: 245 Main Street, Cambridge, MA, United States, 02142
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11.21 USDP/E ratio
–Dividend Yield
–Current Year
+455 USD
Last Year
+316 952 USD
Current Quarter
–
Last Quarter
–
Current Year
-764 138 USD
Last Year
+158 830 USD
Current Quarter
-175 482 USD
Last Quarter
-187 681 USD
Key Figures IMRX
1 year
3 years
5 years
10 years
EBITDA
-60 089 768 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.42 %
PEG Ratio
–
Return On Equity TTM
-61.81 %
Wall Street Target Price
11.21 USD
Revenue TTM
455 USD
Book Value
2.24 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-99.8 %
Dividend Yield
–
Gross Profit TTM
158 830 USD
Earnings per share
-1.9 USD
Diluted Eps TTM
-1.9 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics IMRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IMRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation IMRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
191913.5363
Price Sales TTM
563.6155
Enterprise Value EBITDA
-1.5343
Price Book MRQ
0.8363
Financials IMRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IMRX
For 52 weeks
1 USD
8.89 USD
50 Day MA
2.02 USD
Shares Short Prior Month
1 633 767
200 Day MA
2.57 USD
Short Ratio
0.18
Shares Short
1 519 217
Short Percent
6.88 %
BeatStart